Life Sciences

Ireland is a globally recognised centre of excellence for life sciences, pharma and medtech companies, ranging from global multinationals to an increasing number of vibrant indigenous companies.

Our life sciences team, drawn from specialist practice areas across the firm, offers commercial and practical advice to global players and emerging companies alike. Our key strength is our industry knowledge and expertise.  

Martin Kelleher, who leads the team, spent almost a decade as in-house counsel to Elan Corporation plc, a global biopharmaceutical company. Many of our lawyers have backgrounds in industry, science and medicine.

Life sciences companies require a special blend of legal advice and industry knowledge and we advise on a variety of issues including the development, protection and licensing of intellectual property, commercial contracts, clinical and regulatory matters as well as financing and funding, taxation, and mergers and acquisitions.

We also advise on a number of other areas affecting the life sciences sector, such as employment - including business immigration, competition law, public procurement, privacy and data security and technology law.

Our Services

  • Mergers & Acquisition
  • Commercial Contracts
  • Intellectual Property
  • Regulation: regulatory framework and enforcement
  • Healthcare:
    • Clinical trials and investigations
    • The regulation of hospitals, nursing homes, primary care clinics and other healthcare institutions
    • Healthcare ethics
  • Product Liability
  • Funding
  • Taxation


Legal 500, 2021

Tier 1 ranked team. “Excellent service and advice provided by a professional team. Always a pleasure to deal with”.

Chambers & Partners, 2020

Sources praise the team's "good depth of experience". 

Recent Work

  • Advised McKesson Corporation on its acquisition of the pharmaceutical distribution business of Irish FTSE 250 company, UDG Healthcare plc for €408m.
  • Advised the shareholders of Genable Technologies Limited, an Irish privately held venture-capital backed biopharmaceutical company, on the sale of the company to Spark Therapeutics Inc., a NASDAQ listed leading US gene therapy company.
  • Acting for a multinational pharmaceutical company in patent revocation/ infringement proceedings before the Commercial Court regarding the asthma treatment combination Budesonide/ Formoterol.
  • LinkedIn


Martin Kelleher